212 related articles for article (PubMed ID: 21859887)
1. ICH S9: Developing anticancer drugs, one year later.
Ponce R
Toxicol Pathol; 2011 Oct; 39(6):913-5. PubMed ID: 21859887
[TBL] [Abstract][Full Text] [Related]
2. International Conference on Harmonisation; Guidance on S9 Nonclincal Evaluation for Anticancer Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Mar; 75(44):10487-8. PubMed ID: 20383918
[TBL] [Abstract][Full Text] [Related]
3. International Conference on Harmonisation; Guidance on M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Jan; 75(13):3471-2. PubMed ID: 20349552
[TBL] [Abstract][Full Text] [Related]
4. International Conference on Harmonisation; addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2012 May; 77(97):29665-6. PubMed ID: 22616137
[TBL] [Abstract][Full Text] [Related]
5. International Conference on Harmonisation; guidance on S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2005 Oct; 70(202):61133-4. PubMed ID: 16237859
[TBL] [Abstract][Full Text] [Related]
6. International Conference on Harmonisation: guidance on testing for carcinogenicity of pharmaceuticals. Notice. Food and Drug Administration, HHS.
Fed Regist; 1998 Feb; 63(35):8983-6. PubMed ID: 12269370
[TBL] [Abstract][Full Text] [Related]
7. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for use in the International Conference on Harmonisation Regions; Annex 4C on Microbiological Examination of Nonsterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Apr; 74(66):15992-3. PubMed ID: 19507323
[TBL] [Abstract][Full Text] [Related]
8. International Conference on Harmonisation; guidance on S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals intended for Human Use; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2012 Jun; 77(110):33748-9. PubMed ID: 22675782
[TBL] [Abstract][Full Text] [Related]
9. Statistical concepts in the planning and evaluation of drug safety from clinical trials in drug development: issues of international harmonization.
O'Neill RT
Stat Med; 1995 May 15-30; 14(9-10):117-27. PubMed ID: 7569506
[TBL] [Abstract][Full Text] [Related]
10. Regulatory aspects of oncology drug safety evaluation: past practice, current issues, and the challenge of new drugs.
Rosenfeldt H; Kropp T; Benson K; Ricci MS; McGuinn WD; Verbois SL
Toxicol Appl Pharmacol; 2010 Mar; 243(2):125-33. PubMed ID: 20045015
[TBL] [Abstract][Full Text] [Related]
11. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Jul; 66(135):36791-2. PubMed ID: 12356097
[TBL] [Abstract][Full Text] [Related]
12. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex on Test for Extractable Volume of Parenteral Preparations General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Jan; 74(6):908-9. PubMed ID: 20333832
[TBL] [Abstract][Full Text] [Related]
13. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 7 on Dissolution Test General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Apr; 75(64):17148-9. PubMed ID: 20383923
[TBL] [Abstract][Full Text] [Related]
14. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial texts for use in the International Conference on Harmonisation Regions; Annex 12 on Analytical Sieving General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Sep; 75(170):53873-4. PubMed ID: 20812423
[TBL] [Abstract][Full Text] [Related]
15. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 9 on Tablet Friability General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Apr; 75(64):17147-8. PubMed ID: 20383922
[TBL] [Abstract][Full Text] [Related]
16. International Conference on Harmonisation; guidance on M4 common technical document; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Oct; 66(200):52634-7. PubMed ID: 12358037
[TBL] [Abstract][Full Text] [Related]
17. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 5 on Disintegration Test General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Dec; 74(245):68270-1. PubMed ID: 20344862
[TBL] [Abstract][Full Text] [Related]
18. International Conference on Harmonisation; Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2006 Apr; 71(71):19193-4. PubMed ID: 16612859
[TBL] [Abstract][Full Text] [Related]
19. International Conference on Harmonisation; Guidance on Q8 Pharmaceutical Development; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2006 May; 71(98):29344-5. PubMed ID: 16749216
[TBL] [Abstract][Full Text] [Related]
20. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 8 on Sterility Test General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Dec; 74(244):68068-9. PubMed ID: 20336863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]